LXRX
Lexicon Pharmaceuticals Inc
1.70$
-4.5%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 189.5% | 175.4% | 1.2% | 4.5% | 2.2% | 1.6% | 2.1% | 6.1% | 8.0% | 3.3% | 6.0% | 13.7% | 0.2% | 8.9% | 7.1% | 7.9% | 9.5% | 498.5% | 46,700.0% | 4,383.3% | 68,182.6% | 117,842.9% | 294.6% | 305.7% | 276.9% | 367.9% | 466.7% | 2.5% | 4.3% | 2,112.8% | 15.5% | 10.1% | 4.1% | 97.7% | 2.4% | 0.7% | 0.1% | 5.8% | 0.5% | 5.6% | 1.1% | |
| -89.5% | -75.4% | 98.8% | 95.5% | 97.8% | 98.4% | 97.9% | 93.9% | 92.0% | 96.7% | 94.0% | 86.3% | 99.8% | 91.1% | 92.9% | 92.1% | 90.5% | -398.5% | -46,600.0% | -4,283.3% | 100.0% | -117,742.9% | -194.6% | 100.0% | 100.0% | -267.9% | 100.0% | 97.5% | 95.7% | -2,012.8% | 84.5% | 89.9% | 95.9% | 2.3% | 97.6% | 99.3% | 99.9% | 94.2% | 99.5% | 94.4% | 98.9% | |
| 189.5% | 175.4% | 238.2% | 223.5% | 145.3% | 142.7% | 189.6% | 193.3% | 200.8% | 72.1% | 130.4% | 130.5% | 9.1% | 465.3% | 689.8% | 625.4% | 605.2% | 498.5% | 46,700.0% | 4,383.3% | 68,182.6% | 117,842.9% | 40,045.9% | 38,160.0% | 27,069.2% | 49,550.0% | 50,108.3% | 4,587.1% | 10,838.3% | 2,102.8% | 1,259.1% | 1,071.2% | 1,473.1% | 100.5% | 1,212.6% | 53.9% | 132.3% | 203.8% | 60.4% | 2,520.7% | 145.1% | |
| 44.2% | 60.6% | 81.3% | 153.3% | 62.1% | 48.8% | 58.9% | 121.8% | 227.2% | 97.0% | 179.7% | 147.3% | 4.7% | 166.9% | 183.6% | 154.0% | 180.8% | 23.7% | 174.9% | 3,391.5% | 31,752.2% | 56,685.7% | 22,948.6% | 30,531.4% | 32,248.7% | 38,164.3% | 79,750.0% | 9,466.2% | 1,580.9% | 4,954.6% | 2,837.2% | 2,379.6% | 2,262.4% | 121.5% | 919.8% | 32.4% | 53.6% | 159.4% | 43.8% | 1,409.0% | 85.2% | |
| 233.8% | 236.0% | 319.5% | 376.7% | 207.3% | 191.5% | 248.5% | 315.2% | 428.1% | 169.1% | 283.6% | 277.8% | 13.8% | 632.2% | 873.5% | 796.8% | -1,216.1% | 3,349.2% | 30,581.5% | 3,391.5% | 99,934.8% | 63,185.7% | 62,994.6% | 68,691.4% | 59,317.9% | 107,867.9% | 129,858.3% | 14,053.3% | 30,732.1% | 4,644.9% | 4,096.3% | 3,450.8% | 3,735.5% | 125.6% | 2,132.4% | 86.3% | 185.9% | 363.3% | 104.2% | 3,929.6% | 230.3% | |
| -126.0% | -136.0% | -232.2% | -281.2% | -109.6% | -93.2% | -150.6% | -221.3% | -336.1% | -72.4% | -189.6% | -191.5% | 76.3% | -541.0% | -780.6% | -704.8% | 1,306.5% | -3,747.7% | -77,181.5% | -7,674.8% | -99,834.8% | -180,928.6% | -63,189.2% | -68,591.4% | -59,217.9% | -108,135.7% | -129,758.3% | -13,955.8% | -30,636.4% | -6,657.7% | -4,011.8% | -3,360.9% | -3,639.6% | -123.3% | -2,034.8% | 12.9% | -85.9% | -269.1% | -4.7% | -3,835.3% | -131.4% | |
| 5.9% | 7.1% | 8.7% | 13.4% | 6.0% | 6.5% | 20.3% | 37.7% | 76.6% | 30.6% | 55.5% | 53.3% | 1.8% | 59.5% | 64.1% | 55.9% | 62.1% | 85.4% | 618.5% | 72.2% | 743.5% | 2,107.1% | 297.3% | 2,008.6% | 2,215.4% | 3,939.3% | 7,587.5% | 618.3% | 2,406.8% | 772.2% | 437.9% | 134.2% | 260.7% | 14.5% | 145.4% | 8.0% | 15.2% | 37.0% | 7.5% | 377.0% | 20.2% | |
| -129.9% | -140.7% | -238.0% | -290.9% | -114.0% | -98.0% | -166.9% | -252.4% | -401.3% | -98.3% | -236.5% | -237.7% | 74.7% | -586.0% | -832.7% | -753.8% | 1,245.1% | -2,761.3% | -77,622.2% | -7,720.9% | -100,530.4% | -182,935.7% | -63,448.6% | -70,248.6% | -59,966.7% | -108,907.1% | -133,058.3% | -14,165.3% | -31,188.3% | -7,087.7% | -4,282.9% | -3,244.0% | -3,703.5% | -127.2% | -2,004.4% | 11.3% | -90.0% | -282.7% | -4.9% | -4,591.8% | -147.4% | |
| 4.1% | 0.2% | -47.3% | 17.1% | 7.5% | -12.1% | 24.3% | 44.3% | 11.4% | -0.6% | 8.6% | -2.3% | -2.0% | 3.8% | 12.0% | 55.9% | 62.1% | -87.4% | 177.8% | 8.1% | -391.3% | -100.0% | 259.5% | 1,657.1% | 748.7% | 771.4% | -4,287.5% | 363.4% | 1,761.7% | -424.1% | 8.9% | – | – | -0.4% | – | – | – | – | – | – | – | |
| -129.9% | -140.7% | -190.7% | -290.9% | -114.0% | -85.9% | -166.9% | -252.4% | -401.3% | -98.3% | -236.5% | -237.7% | 76.8% | -586.0% | -832.7% | -753.8% | 1,245.1% | -2,761.3% | -77,622.2% | -7,720.9% | -100,530.4% | -182,935.7% | -63,448.6% | -70,248.6% | -59,966.7% | -108,907.1% | -133,058.3% | -14,165.3% | -31,188.3% | -7,087.7% | -4,282.9% | -3,244.0% | -3,703.5% | -127.2% | -2,004.4% | 11.3% | -90.0% | -282.7% | -4.9% | -4,591.8% | -147.4% | |
| -122.2% | -131.4% | -225.9% | -269.9% | -104.6% | -87.0% | -143.0% | -208.6% | -311.3% | -62.4% | -171.2% | -175.0% | 76.8% | -515.8% | -757.3% | -688.0% | 1,319.0% | -2,854.8% | -76,866.7% | -7,630.8% | -99,347.8% | -180,028.6% | -62,856.8% | -67,934.3% | -57,474.4% | -104,600.0% | -125,004.2% | -13,501.6% | -28,688.3% | -6,431.6% | -3,933.9% | -3,101.3% | -3,435.6% | -76.5% | -1,845.0% | 19.9% | -73.8% | -243.6% | 3.1% | -4,200.0% | -126.0% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.